ProPhase Labs (PRPH) Revenue & Revenue Breakdown
ProPhase Labs Revenue Highlights
Latest Revenue (Y)
$45.24M
Latest Revenue (Q)
$3.15M
Main Segment (Y)
Diagnostic Services
ProPhase Labs Revenue by Period
ProPhase Labs Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $45.24M | -63.12% |
| 2022-12-31 | $122.65M | 55.17% |
| 2021-12-31 | $79.04M | 444.59% |
| 2020-12-31 | $14.51M | 46.96% |
| 2019-12-31 | $9.88M | -24.76% |
| 2018-12-31 | $13.13M | 33.03% |
| 2017-12-31 | $9.87M | -53.05% |
| 2016-12-31 | $21.01M | 1.99% |
| 2015-12-31 | $20.60M | -6.64% |
| 2014-12-31 | $22.07M | -11.83% |
| 2013-12-31 | $25.03M | 11.72% |
| 2012-12-31 | $22.41M | 28.38% |
| 2011-12-31 | $17.45M | 20.35% |
| 2010-12-31 | $14.50M | -26.82% |
| 2009-12-31 | $19.82M | -3.37% |
| 2008-12-31 | $20.51M | -48.05% |
| 2007-12-31 | $39.48M | -6.29% |
| 2006-12-31 | $42.12M | -21.49% |
| 2005-12-31 | $53.66M | 22.09% |
| 2004-12-31 | $43.95M | 5.90% |
| 2003-12-31 | $41.50M | 41.05% |
| 2002-12-31 | $29.42M | 19.26% |
| 2001-12-31 | $24.67M | 27.40% |
| 2000-12-31 | $19.36M | -21.92% |
| 1999-12-31 | $24.80M | -31.87% |
| 1998-12-31 | $36.40M | -48.15% |
| 1997-12-31 | $70.20M | 8675.00% |
| 1996-12-31 | $800.00K | - |
ProPhase Labs generated $45.24M in revenue during NA 2023, up -63.12% compared to the previous quarter, and up 344.63% compared to the same period a year ago.
ProPhase Labs Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | $3.15M | 27.16% |
| 2024-06-30 | $2.47M | -31.92% |
| 2024-03-31 | $3.63M | 3.86% |
| 2023-12-31 | $3.50M | -58.17% |
| 2023-09-30 | $8.37M | -36.71% |
| 2023-06-30 | $13.22M | -31.53% |
| 2023-03-31 | $19.30M | -11.55% |
| 2022-12-31 | $21.82M | -9.82% |
| 2022-09-30 | $24.20M | -16.82% |
| 2022-06-30 | $29.09M | -38.79% |
| 2022-03-31 | $47.53M | 5.26% |
| 2021-12-31 | $45.16M | 376.74% |
| 2021-09-30 | $9.47M | 3.61% |
| 2021-06-30 | $9.14M | -40.13% |
| 2021-03-31 | $15.27M | 195.78% |
| 2020-12-31 | $5.16M | 34.45% |
| 2020-09-30 | $3.84M | 5.99% |
| 2020-06-30 | $3.62M | 91.90% |
| 2020-03-31 | $1.89M | -39.89% |
| 2019-12-31 | $3.14M | 13.56% |
| 2019-09-30 | $2.77M | 67.53% |
| 2019-06-30 | $1.65M | -28.77% |
| 2019-03-31 | $2.32M | -43.37% |
| 2018-12-31 | $4.09M | 67.81% |
| 2018-09-30 | $2.44M | -23.45% |
| 2018-06-30 | $3.19M | -6.49% |
| 2018-03-31 | $3.41M | -17.92% |
| 2017-12-31 | $4.15M | 36.55% |
| 2017-09-30 | $3.04M | 59.58% |
| 2017-06-30 | $1.91M | 147.08% |
| 2017-03-31 | $771.00K | -89.87% |
| 2016-12-31 | $7.61M | 46.67% |
| 2016-09-30 | $5.19M | 82.23% |
| 2016-06-30 | $2.85M | -46.98% |
| 2016-03-31 | $5.37M | -34.22% |
| 2015-12-31 | $8.16M | 85.95% |
| 2015-09-30 | $4.39M | 100.37% |
| 2015-06-30 | $2.19M | -62.61% |
| 2015-03-31 | $5.86M | -34.69% |
| 2014-12-31 | $8.97M | 74.89% |
| 2014-09-30 | $5.13M | 185.48% |
| 2014-06-30 | $1.80M | -70.88% |
| 2014-03-31 | $6.17M | -35.73% |
| 2013-12-31 | $9.60M | 61.41% |
| 2013-09-30 | $5.95M | 206.81% |
| 2013-06-30 | $1.94M | -74.29% |
| 2013-03-31 | $7.54M | -16.92% |
| 2012-12-31 | $9.08M | 67.65% |
| 2012-09-30 | $5.42M | 185.90% |
| 2012-06-30 | $1.89M | -68.53% |
| 2012-03-31 | $6.02M | -19.34% |
| 2011-12-31 | $7.46M | 46.78% |
| 2011-09-30 | $5.08M | 191.46% |
| 2011-06-30 | $1.74M | -44.91% |
| 2011-03-31 | $3.17M | -48.87% |
| 2010-12-31 | $6.19M | 18.99% |
| 2010-09-30 | $5.20M | 360.12% |
| 2010-06-30 | $1.13M | -42.76% |
| 2010-03-31 | $1.98M | -78.30% |
| 2009-12-31 | $9.10M | 82.92% |
| 2009-09-30 | $4.98M | 184.75% |
| 2009-06-30 | $1.75M | -56.16% |
| 2009-03-31 | $3.99M | -41.19% |
| 2008-12-31 | $6.78M | 6.68% |
| 2008-09-30 | $6.35M | 207.23% |
| 2008-06-30 | $2.07M | -61.01% |
| 2008-03-31 | $5.31M | -60.90% |
| 2007-12-31 | $13.57M | - |
ProPhase Labs generated $3.15M in revenue during Q3 2024, up 27.16% compared to the previous quarter, and up 23.80% compared to the same period a year ago.
ProPhase Labs Revenue Breakdown
ProPhase Labs Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 22 | Dec 21 |
|---|---|---|
| Diagnostic Services | $108.33M | $68.56M |
| Consumer Products | $14.32M | $10.48M |
Latest
ProPhase Labs's latest annual revenue breakdown by segment (product or service), as of Dec 22: Diagnostic Services (88.33%), and Consumer Products (11.67%).
Quarterly Revenue by Product
| Product/Service | Jun 24 | Mar 24 | Sep 23 | Jun 23 | Mar 23 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Consumer Products | $2.47M | $3.63M | $5.87M | $5.38M | $4.78M | $3.66M | $2.93M | $2.62M | $4.01M | $2.33M | $1.60M | $2.53M |
| Diagnostic Services | - | - | $2.49M | $7.83M | $14.52M | $20.54M | $26.16M | $44.91M | $41.14M | $7.14M | $7.50M | $12.74M |
Latest
ProPhase Labs's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Consumer Products (100.00%).
ProPhase Labs Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| SHC | Sotera Health Company | $1.05B | $285.47M |
| GTH | Genetron | $650.71M | $201.32M |
| BNR | Burning Rock Biotech | $537.43M | $125.62M |
| LMDX | LumiraDx | $254.48M | $21.00M |
| OLK | Olink AB (publ) | $169.91M | $28.59M |
| STIM | Neuronetics | $71.35M | $16.45M |
| XGN | Exagen | $52.55M | $15.06M |
| BDSX | Biodesix | $49.09M | $18.15M |
| STRR | Star Equity | $45.78M | $13.48M |
| PRPH | ProPhase Labs | $45.24M | $3.15M |
| ENZ | Enzo Biochem | $31.91M | $8.02M |
| PMD | Psychemedics | $22.10M | $5.17M |
| DRIO | DarioHealth | $20.35M | $6.25M |
| PRPO | Precipio | $12.40M | $4.44M |
| INBS | Intelligent Bio Solutions | $3.11M | $872.29K |
| SERA | Sera Prognostics | $306.00K | $24.00K |